Homocysteinemia as a Risk Factor for Atherosclerosis: A Review
- 1 January 1997
- journal article
- review article
- Published by Elsevier in Cardiovascular Pathology
- Vol. 6 (1) , 1-9
- https://doi.org/10.1016/s1054-8807(96)00064-6
Abstract
No abstract availableKeywords
This publication has 62 references indexed in Scilit:
- A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductaseNature Genetics, 1995
- Plasma homocysteine concentrations in Japanese patients with non-insulin-dependent diabetes mellitus: effect of parenteral methylcobalamin treatmentAtherosclerosis, 1993
- Cobalamin absorption and serum homocysteine and methylmalonic acid in elderly subjects with low serum cobalaminEuropean Journal of Haematology, 1993
- Elevated plasma homocyst(e)ine concentration as a possible independent risk factor for stroke.Stroke, 1990
- Heterozygosity for Homocystinuria in Premature Arterial DiseaseNew England Journal of Medicine, 1986
- Heterozygosity for Homocystinuria in Premature Peripheral and Cerebral Occlusive Arterial DiseaseNew England Journal of Medicine, 1985
- Protein‐bound plasma homocyst(e)ine and identification of heterozygotes for cystathionine‐synthase deficiencyJournal of Inherited Metabolic Disease, 1985
- Homocystinuria — The Effects of Betaine in the Treatment of Patients Not Responsive to PyridoxineNew England Journal of Medicine, 1983
- Homocystinuria associated with decreased methylenetetrahydrofolate reductase activityBiochemical and Biophysical Research Communications, 1972
- The identification of homocystine in the urineBiochemical and Biophysical Research Communications, 1962